Page last updated: 2024-10-22

amobarbital and Adrenal Cancer

amobarbital has been researched along with Adrenal Cancer in 2 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
PĂ©ron, FG1
Haksar, A1
Lin, M1
Kupfer, D1
Robidoux, W1
Kimmel, G1
Bedigian, E1
Kowal, J1
Harano, Y1

Other Studies

2 other studies available for amobarbital and Adrenal Cancer

ArticleYear
Studies on respiration and 11 beta-hydroxylation of deoxycorticosterone in mitochondria and intact cells isolated from the Snell adrenocortical carcinoma 494.
    Cancer research, 1974, Volume: 34, Issue:10

    Topics: Adrenal Gland Neoplasms; Adrenal Glands; Amobarbital; Animals; Cell-Free System; Corticosterone; Cya

1974
Adrenal cells in tissue culture. The effect of papaverine and amytal on steroidogenesis, respiration and replication.
    Archives of biochemistry and biophysics, 1974, Volume: 163, Issue:2

    Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotrop

1974